Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of PCV-free liquid versus lyophilized Rotarix in infants
2018-001986-18Phase 3
- Sponsor
- GSK
- Start
- Jul 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of human rotavirus RIX4414 strain vaccine in rotaviral diarrhea (2 arms), sponsored by GSK. Primary endpoints: Percentage of subjects with any solicited general adverse events and Reactogenicity assessment.
02
Drugs
human rotavirus RIX4414 strain vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2018-001986-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001986-18.